HLB TherapeuticsLtd Balance Sheet Health
Financial Health criteria checks 6/6
HLB TherapeuticsLtd has a total shareholder equity of ₩168.6B and total debt of ₩17.2B, which brings its debt-to-equity ratio to 10.2%. Its total assets and total liabilities are ₩204.2B and ₩35.6B respectively.
Key information
10.2%
Debt to equity ratio
₩17.22b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩29.95b |
| Equity | ₩168.62b |
| Total liabilities | ₩35.56b |
| Total assets | ₩204.18b |
Recent financial health updates
Is HLB TherapeuticsLtd (KOSDAQ:115450) A Risky Investment?
Sep 25
Does G-treeBNT (KOSDAQ:115450) Have A Healthy Balance Sheet?
Mar 19Recent updates
HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Shares Climb 36% But Its Business Is Yet to Catch Up
Nov 18What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 36% Share Price Gain Is Not Telling You
Nov 18Is HLB TherapeuticsLtd (KOSDAQ:115450) A Risky Investment?
Sep 25What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 27% Share Price Gain Is Not Telling You
Jul 22HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Popularity With Investors Under Threat As Stock Sinks 26%
Jun 03HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 38% Share Price Surge Not Quite Adding Up
Apr 11There's Reason For Concern Over HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Massive 50% Price Jump
Feb 26Does G-treeBNT (KOSDAQ:115450) Have A Healthy Balance Sheet?
Mar 19Did Business Growth Power G-treeBNT's (KOSDAQ:115450) Share Price Gain of 134%?
Dec 21
Financial Position Analysis
Short Term Liabilities: A115450's short term assets (₩59.5B) exceed its short term liabilities (₩17.5B).
Long Term Liabilities: A115450's short term assets (₩59.5B) exceed its long term liabilities (₩18.0B).
Debt to Equity History and Analysis
Debt Level: A115450 has more cash than its total debt.
Reducing Debt: A115450's debt to equity ratio has reduced from 54.6% to 10.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A115450 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A115450 has sufficient cash runway for 2.3 years if free cash flow continues to grow at historical rates of 0.6% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 20:39 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HLB Therapeutics Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jae Kim | DAOL Investment & Securities Co., Ltd. |
| Seung Kyu Jung | Kiwoom Securities Co., Ltd. |